Bridget E. Bunner

Array ( [id] => 6510519 [patent_doc_number] => 20100261207 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-10-14 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/295572 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 210593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0261/20100261207.pdf [firstpage_image] =>[orig_patent_app_number] => 12295572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6510519 [patent_doc_number] => 20100261207 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-10-14 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/295572 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 210593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0261/20100261207.pdf [firstpage_image] =>[orig_patent_app_number] => 12295572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483298 [patent_doc_number] => 20100008936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'IL-16 antagonist peptides and DNA encoding the peptides' [patent_app_type] => utility [patent_app_number] => 11/725090 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8995 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008936.pdf [firstpage_image] =>[orig_patent_app_number] => 11725090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543369 [patent_doc_number] => 08318660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Method of treating a disease by administering caspase-8' [patent_app_type] => utility [patent_app_number] => 12/282747 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 12450 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12282747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811326 [patent_doc_number] => 08133857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'NOTCH inhibition in the treatment of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/230867 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8092 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133857.pdf [firstpage_image] =>[orig_patent_app_number] => 12230867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514123 [patent_doc_number] => 20090214429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO TARGETING TUMORS AND WOUNDS' [patent_app_type] => utility [patent_app_number] => 12/162751 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24234 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214429.pdf [firstpage_image] =>[orig_patent_app_number] => 12162751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948948 [patent_doc_number] => 20080305074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Stem cell factor' [patent_app_type] => utility [patent_app_number] => 11/702389 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 120 [patent_no_of_words] => 52398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305074.pdf [firstpage_image] =>[orig_patent_app_number] => 11702389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068922 [patent_doc_number] => 20070190023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Methods and compositions for modulating the mobilization of stem cells' [patent_app_type] => utility [patent_app_number] => 11/698291 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50409 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190023.pdf [firstpage_image] =>[orig_patent_app_number] => 11698291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8005655 [patent_doc_number] => 08084228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Nogo-B receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/087435 [patent_app_country] => US [patent_app_date] => 2007-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 68 [patent_no_of_words] => 15413 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084228.pdf [firstpage_image] =>[orig_patent_app_number] => 12087435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348844 [patent_doc_number] => 20090004205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Prospective identification and characterization of breast cancer stem cells' [patent_app_type] => utility [patent_app_number] => 11/651214 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 61051 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004205.pdf [firstpage_image] =>[orig_patent_app_number] => 11651214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219342 [patent_doc_number] => 20070160653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Hemostatic textile' [patent_app_type] => utility [patent_app_number] => 11/650670 [patent_app_country] => US [patent_app_date] => 2007-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10082 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160653.pdf [firstpage_image] =>[orig_patent_app_number] => 11650670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386273 [patent_doc_number] => 20090227518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/719200 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18416 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227518.pdf [firstpage_image] =>[orig_patent_app_number] => 11719200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 70844 [patent_doc_number] => 07754206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Method for treating cancer using a Notch4 ligand antagonist' [patent_app_type] => utility [patent_app_number] => 11/607780 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 62 [patent_no_of_words] => 61273 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754206.pdf [firstpage_image] =>[orig_patent_app_number] => 11607780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839384 [patent_doc_number] => 20080279869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'METHOD FOR REDUCING NEURONAL DEGENERATION BY ADMINISTERING CNS-DERIVED PEPTIDES OR ACTIVATED T CELLS' [patent_app_type] => utility [patent_app_number] => 11/563630 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16824 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279869.pdf [firstpage_image] =>[orig_patent_app_number] => 11563630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367751 [patent_doc_number] => 20090305310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods for Determining Notch Signaling and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/085425 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 36176 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305310.pdf [firstpage_image] =>[orig_patent_app_number] => 12085425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 220862 [patent_doc_number] => 07608408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Methods of identifying compounds that inhibit Notch cleavage' [patent_app_type] => utility [patent_app_number] => 11/595721 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 6948 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608408.pdf [firstpage_image] =>[orig_patent_app_number] => 11595721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079198 [patent_doc_number] => 20070122422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids' [patent_app_type] => utility [patent_app_number] => 11/595651 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11764 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122422.pdf [firstpage_image] =>[orig_patent_app_number] => 11595651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322726 [patent_doc_number] => 07517959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'SOCS3 proteins' [patent_app_type] => utility [patent_app_number] => 11/598212 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 18782 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517959.pdf [firstpage_image] =>[orig_patent_app_number] => 11598212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314536 [patent_doc_number] => 07524505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Compositions and methods for dual therapies of hair graying and balding in follicular delivery systems' [patent_app_type] => utility [patent_app_number] => 11/557960 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7398 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524505.pdf [firstpage_image] =>[orig_patent_app_number] => 11557960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436217 [patent_doc_number] => 20090170804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PIRFENIDONE/TOLL-LIKE RECEPTOR (TLR) AGONIST COMPOSITIONS AND METHODS FOR USING THEM TO STIMULATE PRODUCTION OF GRANULOCYTE COLONIZING STIMULATING FACTOR (G-CSF)' [patent_app_type] => utility [patent_app_number] => 12/091153 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10341 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170804.pdf [firstpage_image] =>[orig_patent_app_number] => 12091153 [rel_patent_id] =>[rel_patent_doc_number] =>)